TIMOTHY A. SPRINGER - 11 Apr 2022 Form 4 Insider Report for SELECTA BIOSCIENCES INC (SELB)

Role: Director, 10%+ Owner
Signature: /s/ Matthew Bartholomae, Attorney-in-Fact for Timothy A. Springer
Issuer symbol: SELB
Transactions as of: 11 Apr 2022
Transactions value $: $0
Form type: 4
Filing time: 13 Apr 2022, 21:07:18 UTC
Previous filing: 05 Jan 2022
Next filing: 10 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SELB	Common Stock	Purchase		+6.68M	+28.82%		29.9M	11 Apr 2022	See Footnote	F1, F2
holding	SELB	Common Stock						7.29M	11 Apr 2022	Direct
holding	SELB	Common Stock						86.4K	11 Apr 2022	By wife

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SELB	Warrant (right to buy)	Award		+5.01M			5.01M	11 Apr 2022	Common Stock	5.01M	$1.55	See Footnote	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each share of common stock and accompanying warrant to purchase 0.75 shares of common stock was purchased at a combined ofering price of $1.41. The shares of common stock and accompanying warrants were acquired by the reporting person as units, but were issued separately and were immediately separable upon issuance.
F2	Held by TAS Partners LLC. The reporting person is the managing member of TAS Partners LLC. The reporting person disclaims beneficial ownership of the securities held by TAS Partners LLC except to the extent of his pecuniary interest therein, if any.